Colin John Meyer is Chief Innovation Officer of Reata Pharmaceuticals Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
REATA PHARMACEUTICALS INC
26 Sep 23
4
REATA PHARMACEUTICALS INC
17 Aug 23
144
REATA PHARMACEUTICALS INC
16 Aug 23
144
REATA PHARMACEUTICALS INC
15 Aug 23
4
REATA PHARMACEUTICALS INC
10 Jul 23
4
REATA PHARMACEUTICALS INC
17 May 23
144
REATA PHARMACEUTICALS INC
16 May 23
144
REATA PHARMACEUTICALS INC
15 May 23
4
REATA PHARMACEUTICALS INC
8 Mar 23
4
REATA PHARMACEUTICALS INC
6 Mar 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
26 Sep 23 | RETA Reata Pharmaceuticals | Class A common stock | Sale back to company | Dispose D | No | No | 0 | 81,633 | 0.00 | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Employee Stock Option Class B common stock | Sale back to company | Dispose D | No | No | 207.2 | 25,000 | 5.18 mm | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Employee Stock Option Class B common stock | Sale back to company | Dispose D | No | No | 55.73 | 17,750 | 989.21 k | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Employee Stock Option Class B common stock | Sale back to company | Dispose D | No | No | 55.73 | 17,750 | 989.21 k | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Employee Stock Option Class B common stock | Sale back to company | Dispose D | No | No | 55.73 | 35,500 | 1.98 mm | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Employee Stock Option Class B common stock | Sale back to company | Dispose D | No | No | 24.75 | 87,700 | 2.17 mm | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Employee Stock Option Class B common stock | Sale back to company | Dispose D | No | No | 22.57 | 90,000 | 2.03 mm | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Employee Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 36.71 | 95,475 | 3.50 mm | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Employee Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 27.32 | 70,000 | 1.91 mm | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Employee Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 27.32 | 30,000 | 819.60 k | 0 |